 A ALIMENTARY TRACT AND METABOLISM
|
|
B BLOOD AND BLOOD FORMING ORGANS
|
|
C CARDIOVASCULAR SYSTEM
|
|
D DERMATOLOGICALS
|
|
G GENITO URINARY SYSTEM AND SEX HORMONES
|
|
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
|
|
 J ANTIINFECTIVES FOR SYSTEMIC USE
|
J01 ANTIBACTERIALS FOR SYSTEMIC USE
|
J02 ANTIMYCOTICS FOR SYSTEMIC USE
|
J04 ANTIMYCOBACTERIALS
|
J05 ANTIVIRALS FOR SYSTEMIC USE
|
J05A DIRECT ACTING ANTIVIRALS
|
J05AA Thiosemicarbazones
|
J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors [DG:DG02840]
|
J05AC Cyclic amines
|
J05AD Phosphonic acid derivatives
|
J05AE Protease inhibitors [DG:DG01647]
|
J05AE01 Saquinavir [DG:DG00653]
|
J05AE02 Indinavir [DG:DG00654]
|
J05AE03 Ritonavir
|
J05AE04 Nelfinavir [DG:DG00655]
|
J05AE05 Amprenavir
|
J05AE07 Fosamprenavir [DG:DG00656]
|
 D02497 Fosamprenavir (INN)
D02867 Fosamprenavir calcium hydrate (JAN) <JP>
D03835 Fosamprenavir calcium (USAN) <US>
D03837 Fosamprenavir sodium (USAN)
|
J05AE08 Atazanavir [DG:DG00657]
|
J05AE09 Tipranavir [DG:DG00658]
|
J05AE10 Darunavir [DG:DG00659]
|
J05AE16 Ensitrelvir [DG:DG03269]
|
J05AE30 Nirmatrelvir and ritonavir
|
J05AF Nucleoside and nucleotide reverse transcriptase inhibitors [DG:DG01890]
|
J05AG Non-nucleoside reverse transcriptase inhibitors [DG:DG01889]
|
J05AH Neuraminidase inhibitors [DG:DG02842]
|
J05AJ Integrase inhibitors [DG:DG03135]
|
J05AP Antivirals for treatment of HCV infections
|
J05AR Antivirals for treatment of HIV infections, combinations
|
J05AX Other antivirals
|
J06 IMMUNE SERA AND IMMUNOGLOBULINS
|
J07 VACCINES
|
|
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
|
|
M MUSCULO-SKELETAL SYSTEM
|
|
N NERVOUS SYSTEM
|
|
P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
|
|
R RESPIRATORY SYSTEM
|
|
S SENSORY ORGANS
|
|
V VARIOUS
|
Anatomical Therapeutic Chemical (ATC) Classification